Insights

Browse our collection of educational materials focused on industry trends, case studies and other content to keep you informed. 

Resources

A compilation of external resources providing links to crucial content such as regulations, warning letters, alerts, and databases.

Newsletters

Explore articles crafted by our team of experts, covering pertinent topics related to regulatory affairs, quality management systems, and clinical affairs.

Case Studies

Discover real-life examples of projects we have undertaken, showcasing solutions implemented by AlvaMed to address challenges and deliver effective results.

LinkedIn

Stay connected with us for the latest updates, including news and articles, tailored to assist medical device companies in navigating trends and challenges in regulatory affairs, quality management systems and clinical affairs.

To eQMS or Not: The Enduring Value of a Traditional QMS in a Digital Age

In today’s fast-paced, digital-first world, the allure of electronic Quality Management Systems (eQMS) is undeniable.

CER and Literature Search Remediation

Challenge: Approach: AlvaMed implemented the following approach: Results: AlvaMed delivered the following: Impact: Project is

Impact of Medical Device Supply Chain Vulnerabilities on Public Health

The U.S. Food and Drug Administration (FDA) is focused on preventing and mitigating medical device

Rethinking eQMS: When a Traditional QMS Might be Right

An eQMS system, or electronic Quality Management System, is a software solution designed to automate

Case Study: Navigating Regulatory Challenges to Achieve FDA Clearance

Background and Challenge: A medical device manufacturer sought FDA clearance for its innovative lidocaine delivery

Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices

FDA recently issued a draft guidance document on “Protocol Deviations for Clinical Investigations of Drugs,

Evaluation of Sex-Specific and Gender-Specific Data in Medical Device Clinical Studies

On January 7, 2025, the FDA issued a draft guidance document on “Evaluation of Sex-Specific

Clinical Strategy & Protocol Development

Challenge: A small company specializing in an innovative robotic platform technology for precision surgery in

FDA’s Quality Management Maturity Program

In an era where medical devices and pharmaceuticals are becoming increasingly complex, ensuring their safety

Subscribe To AlvaMed's Newsletter

A monthly analysis of the medical device industry, quality and regulatory developments, and other useful information for industry professionals. (Contact details are never shared outside our organization.)
This field is for validation purposes and should be left unchanged.